Byrne AW, McEvoy D, Collins AB, Hunt K, Casey M, Barber A, etal. (August 2020). "Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases". BMJ Open. 10 (8): e039856. doi: 10.1136/bmjopen-2020-039856. PMC 7409948. PMID 32759252. Further information: COVID-19 vaccine, Workplace hazard controls for COVID-19, Pandemic prevention, Non-pharmaceutical intervention, Preparations prior to COVID-19, COVID-19 surveillance, and COVID-19 apps Without pandemic containment measures–such as social distancing, vaccination, and face masks–pathogens can spread exponentially. [185] This graphic shows how early adoption of containment measures tends to protect wider swaths of the population. See more details› About this data Source: Vaccination data is based on government reports and is provided by the Our World in Data project at the University of Oxford. Data is based on reports at the time of publication. Latest trends a b Gandhi RT, Lynch JB, Del Rio C (October 2020). "Mild or Moderate Covid-19". The New England Journal of Medicine. 383 (18): 1757–1766. doi: 10.1056/NEJMcp2009249. PMID 32329974.

Coronavirus cases, deaths, vaccinations by country Covid map: Coronavirus cases, deaths, vaccinations by country

Confirmed cases and deaths, which are widely considered to be an undercount of the true toll, are counts of individuals whose coronavirus infections were confirmed by a molecular laboratory test. Probable cases and deaths count individuals who meet criteria for other types of testing, symptoms and exposure, as developed by national and local governments. Additionally, people with COVID‑19 and acute respiratory distress syndrome (ARDS) have classical serum biomarkers of CRS, including elevated C-reactive protein (CRP), lactate dehydrogenase (LDH), D-dimer, and ferritin. [148] a b Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, Ma K (February 2021). "A systematic review of asymptomatic infections with COVID-19". Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 54 (1): 12–16. doi: 10.1016/j.jmii.2020.05.001. PMC 7227597. PMID 32425996.COVID-19 vaccine effectiveness estimated using Census 2021 variables, England: 31 March 2021 to 20 March 2022 a b "Naming the coronavirus disease (COVID-19) and the virus that causes it". World Health Organization (WHO). Archived from the original on 28 February 2020 . Retrieved 13 March 2020.

BBC News Covid in Scotland: The latest cases - BBC News

you or a child have a high temperature that last 5 days or more or does not come down with paracetamola b c "Overview of Testing for SARS-CoV-2, the virus that causes COVID-19". U.S. Centers for Disease Control and Prevention (CDC). 11 February 2020 . Retrieved 31 July 2022. CDC (1 September 2022). "Post-COVID Conditions". Centers for Disease Control and Prevention . Retrieved 21 September 2022. Neurologic manifestations include seizure, stroke, encephalitis, and Guillain–Barré syndrome (which includes loss of motor functions). [69] [70] Following the infection, children may develop paediatric multisystem inflammatory syndrome, which has symptoms similar to Kawasaki disease, which can be fatal. [71] [72] In very rare cases, acute encephalopathy can occur, and it can be considered in those who have been diagnosed with COVID‑19 and have an altered mental status. [73]

Covid inquiry: The UK pandemic in numbers - BBC News

McNeil Jr DG (2 February 2020). "Wuhan Coronavirus Looks Increasingly Like a Pandemic, Experts Say". The New York Times. ISSN 0362-4331. Archived from the original on 2 February 2020 . Retrieved 4 April 2020. Symptoms of Coronavirus". U.S. Centers for Disease Control and Prevention (CDC). 22 February 2021. Archived from the original on 4 March 2021 . Retrieved 4 March 2021. July 2, 2020:The United Kingdom changed its methodology to avoid double-counting positive cases. This change, along with a historical revision of data, resulted in a decrease of more than 30,000 cases.Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, overall and by age group, using anonymised linked data from Census 2021. Experimental Statistics. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020). "Features, Evaluation and Treatment Coronavirus (COVID-19)". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32150360 . Retrieved 18 March 2020. diffuse alveolar damage (DAD) with diffuse alveolar exudates. DAD is the cause of acute respiratory distress syndrome (ARDS) and severe hypoxaemia. [119] The University of Oxford's CEBM has pointed to mounting evidence [171] [172] that "a good proportion of 'new' mild cases and people re-testing positives after quarantine or discharge from hospital are not infectious, but are simply clearing harmless virus particles which their immune system has efficiently dealt with" and have called for "an international effort to standardize and periodically calibrate testing" [173] In September 2020, the UK government issued "guidance for procedures to be implemented in laboratories to provide assurance of positive SARS-CoV-2 RNA results during periods of low prevalence, when there is a reduction in the predictive value of positive test results". [174] Imaging A CT scan of a person with COVID-19 shows lesions (bright regions) in the lungs CT scan of rapid progression stage of COVID-19 Chest X-ray showing COVID‑19 pneumonia Self-isolation at home has been recommended for those diagnosed with COVID‑19 and those who suspect they have been infected. Health agencies have issued detailed instructions for proper self-isolation. [255] Many governments have mandated or recommended self-quarantine for entire populations. The strongest self-quarantine instructions have been issued to those in high-risk groups. [256] Those who may have been exposed to someone with COVID‑19 and those who have recently travelled to a country or region with the widespread transmission have been advised to self-quarantine for 14 days from the time of last possible exposure. [257] International travel-related control measures